Peter Cicala
Director/Miembro de la Junta en ETERNA THERAPEUTICS INC. .
Cargos activos de Peter Cicala
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ETERNA THERAPEUTICS INC. | Director/Miembro de la Junta | 12/02/2024 | - |
| Independent Dir/Board Member | 12/02/2024 | - |
Historial de carrera de Peter Cicala
Antiguos cargos conocidos de Peter Cicala.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2020 | 01/03/2021 |
| CELGENE | Corporate Officer/Principal | 01/03/2014 | 01/11/2019 |
| BOUNDLESS BIO, INC. | Fundador | 01/11/2019 | - |
Formación de Peter Cicala.
| Seton Hall University School of Law | Graduate Degree |
| Fairleigh Dickinson University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ETERNA THERAPEUTICS INC. | Health Technology |
| BOUNDLESS BIO, INC. | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Peter Cicala
- Experiencia
